Autopsy report · NCT03787901

Comparing the Ongoing Pregnancy Rate for Vitrification of Day-4 Morula With Day-5 Blast

“Failed to achieve sample size due to COVID19 pandemic”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 1 year 5 months before it stopped.
• 53 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Egyptian Foundation of Reproductive Endocrinology

Sponsor type

University, hospital or other

Conditions

Infertility

Interventions

Morula Vitrification

Participants

53

Sites

4

Countries

Egypt

Trials that died the same way

• Evaluation of Skin Cleansers and Skin Protectants in Management of Incontinence-associated Dermatitis
  “Early termination due to COVID-19 pandemic led to inability to reach planned sample size” (71% match in meaning)
• Hypnosis for Children Undergoing Anorectal Manometry
  “Due to COVID-19 recruitement stopped since intended sample size was an estimation and not based on power calculation” (69% match in meaning)
• Effectiveness of a Case Management Intervention for Alcohol Use-Related Problems in Frequent Users of an Emergency Department
  “Insufficient accrual rate to achieve expected sample size in the context of a global pandemic.” (68% match in meaning)
• Pain Navigator Tool for Self-management in Back Pain: PATiENCe Trial
  “Unable to collect data due to COVID19” (68% match in meaning)
• Oxytocin and Brain Responses in Maternal Addiction
  “Unable to recruit proposed study sample size due to COVID restrictions.” (67% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.